ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, Paige E., Cirrito, John R., Wesson, Daniel W., Lee, C. Y. Daniel, Karlo, J. Colleen, Zinn, Adriana E., Casali, Brad T., Restivo, Jessica L. +5 more·2012·Science

DOI 10.1126/science.1217697

Cited by (1,000)

Items 401–500 of 1,000

Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury
Yasuko Kitagishi, Satoru Matsuda · 2013 · Alzheimer s Research & Therapy
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease
Mancini, Simona, Balducci, Claudia, Micotti, Edoardo, Tolomeo, Daniele, Forloni, Gianluigi, Masserini, Massimo, Re, Francesca · 2017 · Journal of Controlled Release
Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease
Nicholas Francis Fitz, Kyong Nyon Nam, Radosveta P. Koldamova, Iliya M. Lefterov · 2019 · British Journal of Pharmacology
Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease
Ying Zhang, Zhongyu Zhang, Lianwei Li, Kaiyu Xu, Zhanshan Sam Ma, Hei‐Man Chow, Karl Herrup, Jiali Li · 2020 · The FASEB Journal
Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits
Markus P. Kummer, Rafael Schwarzenberger, Sakina Sayah‐Jeanne, Mathieu Dubernet, Robert Walczak, Dean W. Hum, Stephanie Schwartz, Daisy Axt, Michael Thomas Heneka · 2014 · Molecular Neurobiology
Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites
Xiao-kun Zhang, Ying Su, Liqun Chen, Fan Chen, Jie Liu, Hu Zhou · 2014 · Acta Pharmacologica Sinica
Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer’s disease
Yue Wang, Zheng Wu, Yu-Ting Bai, Gang-Yi Wu, Gong Chen · 2017 · Molecular Neurodegeneration
OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice
Chunling Yuan, Xiaoli Guo, Qifan Zhou, Fangyu Du, Wei Jiang, Xiaoyu Zhou, Peng Liu, Tianyan Chi, Xuefei Ji, Jinheng Gao et al. · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer’s disease
Zhi-Hao Wang, Yiyuan Xia, Pai Liu, Xia Liu, Laura E. Edgington‐Mitchell, Kecheng Lei, Shan Ping Yu, Xiaochuan Wang, Keqiang Ye · 2021 · Progress in Neurobiology
Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
Padhi, Dikshaa, Govindaraju, Thimmaiah · 2022 · Journal of Medicinal Chemistry
Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population
Rasmussen, Katrine L., Tybjærg-Hansen, Anne, Nordestgaard, Børge G., Frikke-Schmidt, Ruth · 2016 · Atherosclerosis
Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer’s disease pathology in a mouse model
Zhi-Hao Wang, Yiyuan Xia, Zhourui Wu, Seong Su Kang, Ji-chun Zhang, Pai Liu, Xia Liu, Weihong Song, Vincent Huin, Claire‐Marie Dhaenens et al. · 2021 · Progress in Neurobiology
APOEgenotype-dependent modulation of astrocyte chemokine CCL3 production
Eiron Cudaback, Yue Jin Yang, Thomas Jude Montine, Christopher Dirk Keene · 2014 · Glia
Status and future directions of clinical trials in Alzheimer's disease
Germán Plascencia‐Villa, George L. Perry · 2020 · International review of neurobiology
Biotech giant publishes failures to confirm high-profile science
Baker, Monya · 2016 · Nature
Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
Kwangsik T. Nho, Alexandra Kueider‐Paisley, Matthias Arnold, Siamak MahmoudianDehkordi, Shannon L. Risacher, Gregory Louie, Colette Blach, Rebecca Baillie, Xianlin Han, Gabi Kastenmüller et al. · 2021 · Brain Communications
The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia
Vladimir Lerner, Chanoch Miodownik, Anatoly Gibel, Pinchas Sirota, Ilan Bush, Hadi Elliot, R. Benatov, Michael S. Ritsner · 2013 · The Journal of Clinical Psychiatry
The Association Between Cancer and Dementia: A National Cohort Study in Sweden
Ming Sun, Youxin Wang, Jan Sundquist, Kristina Sundquist, Jianguang Ji · 2020 · Frontiers in Oncology
β-amyloid: The known unknowns
Ayton, Scott, Bush, Ashley I. · 2021 · Ageing Research Reviews
A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models
Kelsey A. Potter–Baker, Madhumitha Ravikumar, Alan Burke, William D. Meador, Kyle T. Householder, Amy C. Buck, Smrithi Sunil, Wade G. Stewart, Jake P. Anna, William H. Tomaszewski et al. · 2014 · Biomaterials
Bexarotene protects against neurotoxicity partially through a PPARγ-dependent mechanism in mice following traumatic brain injury
Junchi He, Han Liu, Jianjun Zhong, Zongduo Guo, Jingchuan Wu, Hongrong Zhang, Zhijian Huang, Li Jiang, Hui Li, Zhaosi Zhang et al. · 2018 · Neurobiology of Disease
Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α
Francisco Sáez-Orellana, Jean‐Noël Octave, Nathalie Pierrot · 2020 · Cells
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
Staurenghi, Erica, Giannelli, Serena, Testa, Gabriella, Sottero, Barbara, Leonarduzzi, Gabriella, Gamba, Paola · 2021 · Antioxidants
Bexarotene modulates retinoid-X-receptor expression and is protective against neurotoxic endoplasmic reticulum stress response and apoptotic pathway activation
Dheer, Yogita, Chitranshi, Nitin, Gupta, Veer, Abbasi, Mojdeh, Mirzaei, Mehdi, You, Yuyi, Chung, Roger, Graham, Stuart L., Gupta, Vivek · 2018 · Molecular Neurobiology
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology
Chemparathy, Augustine, Le Guen, Yann, Chen, Sunny, Lee, Eun-Gyung, Leong, Lesley, Gorzynski, John E., Jensen, Tanner D., Ferrasse, Alexis, Xu, Guangxue, Xiang, Hong et al. · 2024 · Neuron
Functional Neurophysiological Biomarkers of Early-Stage Alzheimer’s Disease: A Perspective of Network Hyperexcitability in Disease Progression
Sean Tok, Abdallah Ahnaou, Wilhelmus H. I. M. Drinkenburg · 2021 · Journal of Alzheimer s Disease
Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids
Milan Fiala, Gijs Kooij, Karen M Wagner, Bruce D. Hammock, Matteo A. Pellegrini · 2017 · The FASEB Journal
Systems healthcare: a holistic paradigm for tomorrow
Massimo S. Fiandaca, Mark E. Mapstone, Elenora E. Connors, Mireille Jacobson, Edwin S. Monuki, Shaista Malik, Fabio M. Macciardi, Howard J. Federoff · 2017 · BMC Systems Biology
Measuring discrimination- and reversal learning in mouse models within 4 days and without prior food deprivation
Esther Remmelink, August Benjamin Smit, Matthijs Verhage, Maarten Loos · 2016 · Learning & Memory
Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
Shun Zhu, Fang Liu, Ruiyuan Zhang, Zongxiang Xiong, Qian Zhang, Li Hao, Shiyin Chen · 2022 · Frontiers in Pharmacology
Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, Marianesan Arockia Babu, Danish Iqbal, Abdulmajeed G. Almutary, Mosleh Mohammad Abomughaid, Mehnaz Kamal, Ana Cláudia Paiva‐Santos, Mohammed Alsaweed et al. · 2024 · Biomedicine & Pharmacotherapy
Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention
Theodore B. VanItallie · 2012 · Metabolism
Peroxisome Proliferator-activated Receptors and Alzheimer's Disease: Hitting the Blood–Brain Barrier
Juan Manuel Zolezzi, Nibaldo C. Inestrosa · 2013 · Molecular Neurobiology
A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer’s Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model
Ih‐Jen Su, Hong Chang, Hui-Chen Wang, Kuen‐Jer Tsai · 2020 · International Journal of Molecular Sciences
Old Drug, New Hope for Alzheimer's Disease
Warren J. Strittmatter · 2012 · Science
HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis
Carla Borràs, Aina Mercer, Sònia Sirisi, Daniel Andres Alcolea, Joan Carles Escolá‐Gil, Francisco Blanco‐Vaca, Mireia Tondo · 2022 · International Journal of Molecular Sciences
In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood–brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging
Emilie Ansciaux, Carmen Burtéa, Sophie Laurent, Déborah Crombez, Denis Nonclercq, Luce Vander Elst, Robert N. Müller · 2014 · Contrast Media & Molecular Imaging
Photonic crystals on copolymer film for label-free detection of DNA hybridization
Han Su, Xin Ran Cheng, Tatsuro Endo, Kağan Kerman · 2017 · Biosensors and Bioelectronics
Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
Yixiu Zhou, Yuhui Sun, Quanhong Ma, Yaobo Liu · 2018 · Cell Stress
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Guilaine K. Boyce, Emily B. Button, S.V. Sonja, Cheryl Lea Wellington · 2017 · Journal of Biomedical Research
Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
Suidan, Georgette L., Ramaswamy, Gayathri · 2019 · International Journal of Molecular Sciences
Therapeutic modulation of retinoid X receptors – SAR and therapeutic potential of RXR ligands and recent patents
Simone Schierle, Daniel Merk · 2019 · Expert Opinion on Therapeutic Patents
Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk
Sreedevi Raman, Nicholas Brookhouser, David A. Brafman · 2020 · Neurobiology of Disease
Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice
Angie C. A. Chiang, Alexandre V. Seua, Pooja Singhmar, Luis D. Arroyo, R. Mahalingam, Jian Hu, A. Kavelaars, C. Heijnen · 2020 · Acta Neuropathologica Communications
Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency
Sebastian P. Fuchs, Anne Rensing‐Ehl, Ulrich Pannicke, Myriam Ricarda Lorenz, Paul Fisch, Yogesh S. Jeelall, Jan Rohr, Carsten Speckmann, Thomas Vraetz, Susan Farmand et al. · 2015 · Blood
Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain Barrier
Corbin J. Bachmeier, David Beaulieu‐Abdelahad, Fiona Crawford, MICHAEL J. MULLAN, Daniel Paris · 2012 · Journal of Molecular Neuroscience
Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment
Milan Fiala, Niccolò Terrando, Jesmond Dalli · 2015 · Journal of Alzheimer s Disease
Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy
Xiaodan Guo, Jianlu Lv, Jian Lu, Lei Fan, Xi Huang, Lihong Hu, Jiaying Wang, Xu Shen · 2017 · Neuropharmacology
Convection-Enhanced Delivery of Neprilysin: A Novel Amyloid-β-Degrading Therapeutic Strategy
Neil U. Barua, James Scott Miners, Alison S. Bienemann, Marcella J. Wyatt, Katharina Welser, Alethea B. Tabor, Helen Claire Hailes, Seth Love, Steven S. Gill · 2012 · Journal of Alzheimer s Disease
Ginsenoside compound K promotes β-amyloid peptide clearance in primary astrocytes via autophagy enhancement
Jinhui Guo, Li Chang, Xin Zhang, Sujuan Pei, MEISHUANG YU, Jianlian Gao · 2014 · Experimental and Therapeutic Medicine
A Transcriptomic Network Identified in Uninfected Macrophages Responding to Inflammation Controls Intracellular Pathogen Survival
Lynette Beattie, Micely D’El-Rei Hermida, John W.J. Moore, Asher Maroof, Najmeeyah Brown, Dimitris Lagos, Paul Martin Kaye · 2013 · Cell Host & Microbe
Retinoid X receptor activation is essential for docosahexaenoic acid protection of retina photoreceptors
Olga Lorena German, Sandra Monaco, Daniela L. Agnolazza, Nora P. Rotstein, Luis E. Politi · 2013 · Journal of Lipid Research
Insight into the Inhibition Effect of Acidulated Serum Albumin on Amyloid β-Protein Fibrillogenesis and Cytotoxicity
Baolong Xie, Xi Li, Xiaoyan Dong, Yan Ping Sun · 2014 · Langmuir
Minor ginsenoside F1 improves memory in APP/PS1 mice
Junho Han, Jung-Pyo Oh, Miran Yoo, Chang-Hao Cui, Byeong-Min Jeon, Sunchang Kim, Jin‐Hee Han · 2019 · Molecular Brain
Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases
Alpana Singh, Rishabh Chaudhary · 2025 · International Immunopharmacology
Synthesis of [11C]Bexarotene by Cu-Mediated [11C]Carbon Dioxide Fixation and Preliminary PET Imaging
Benjamin H. Rotstein, Jacob M. Hooker, Jiyeon Woo, Thomas Lee Collier, Thomas J. Brady, Steven H. Liang, Neil Vasdev · 2014 · ACS Medicinal Chemistry Letters
ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: The impact of retinoids on the thyroid axis
Julia Graeppi-Dulac, Virginie Vlaeminck‐Guillem, Marie Perier‐Muzet, Stéphane Dalle, Jacques Orgiazzi · 2014 · European Journal of Endocrinology
Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
B. Wong, Ya-Hui Hung, A. Bush, J. Duce · 2014 · Frontiers in Aging Neuroscience
Aβ Extraction from Murine Brain Homogenates
Brad T. Casali, Gary E. Landreth · 2016 · BIO-PROTOCOL
Platelet-generated amyloid beta peptides in Alzheimer's disease and glaucoma.
Mikhail Y. Inyushin, Astrid Zayas‐Santiago, Legier V. Rojas, Yuriy V. Kucheryavykh, Lilia Y. Kucheryavykh · 2019 · PubMed
Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
Zhang, Lan, Xia, Yiyuan, Gui, Yuran · 2023 · Frontiers in Aging Neuroscience
CSF beta‐amyloid 1–42 – what are we measuring in Alzheimer's disease?
William T. Hu, Kelly D. Watts, Leslie M. J. Shaw, Jennifer Christina Howell, John Q. Trojanowski, Sundeep S. Basra, Jonathan D. Glass, James J. Lah, Allan I. Levey · 2014 · Annals of Clinical and Translational Neurology
Retinoid X receptor ligands: a patent review (2007 – 2013)
Shoya Yamada, Hiroki Kakuta · 2014 · Expert Opinion on Therapeutic Patents
A Natural‐Product Switch for a Dynamic Protein Interface
Marcel Scheepstra, Lidia Nieto, Anna K. H. Hirsch, Sascha Fuchs, S. Leysen, Chan Vinh Lam, Leslie in het Panhuis, Constant A. A. van Boeckel, Hans Wienk, Rolf Boelens et al. · 2014 · Angewandte Chemie International Edition
Carotenoids and Retinoids: Nomenclature, Chemistry, and Analysis
Earl Howard Harrison, Robert W. Curley · 2016 · Sub-cellular biochemistry/Subcellular biochemistry
A visual tool for defining reproducibility and replicability
Prasad Patil, Roger D. Peng, Jeffrey T. Leek · 2019 · Nature Human Behaviour
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
Antonio Ancidoni, Ilaria Bacigalupo, Giulia Remoli, Eleonora Lacorte, Paola Piscopo, Giulia Sarti, Massimo Corbo, Nicola Vanacore, Marco Canevelli · 2021 · Alzheimer s Research & Therapy
Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β
Amanda B. Chai, Hin Hei Julian Lam, Maaike Kockx, Ingrid C. Gelissen · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases
Wei Liu, Gang Wang, Zhiwen Wang, Guan Wang, Jianping Huang, Bo Liu · 2022 · Drug Discovery Today
Opposing effects ofApoe/Apoa1double deletion on amyloid-β pathology and cognitive performance in APP mice
Nicholas Francis Fitz, Vı́ctor Tapias, Andrea A. Cronican, Emilie L. Castranio, Muzamil Saleem, Alexis Y. Carter, Martina I. Lefterova, Iliya M. Lefterov, Radosveta P. Koldamova · 2015 · Brain
Loss of T cells influences sex differences in behavior and brain structure
Kelly C. Rilett, Miriam Friedel, Jacob Ellegood, Robyn N. MacKenzie, Jason P. Lerch, Jane Allyson Foster · 2015 · Brain Behavior and Immunity
The Continuing Failure of Bexarotene in Alzheimer’s Disease Mice
Claudia Balducci, Alessandra Paladini, Edoardo Micotti, Daniele Tolomeo, Pietro La Vitola, Emanuele Grigoli, Jill C. Richardson, Gianluigi Forloni · 2015 · Journal of Alzheimer s Disease
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
Yusuke Kobayashi, Kouji Banno, Haruko Kunitomi, Eiichiro Tominaga, Daisuke Aoki · 2018 · Journal of Gynecologic Oncology
Bexarotene therapy ameliorates behavioral deficits and induces functional and molecular changes in very-old Triple Transgenic Mice model of Alzheimer´s disease
Jonathan Mauricio Muñoz-Cabrera, Adrián Gabriel Sandoval-Hernández, Andrea Niño, Tatiana Báez, Angie Bustos-Rangel, Gloria Patricia Cardona‐Gómez, Alejandro Múnera, Gonzálo Arboleda · 2019 · PLoS ONE
Epigenetic basis of Alzheimer disease
Ángeles C. Tecalco-Cruz, Josué O. Ramírez‐Jarquín, María Elizbeth Álvarez-Sánchez, Jesús Zepeda–Cervantes · 2020 · World Journal of Biological Chemistry
Amyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type
Kamp, Juliette A., Moursel, Laure Grand, Haan, Joost, Terwindt, Gisela M., Lesnik Oberstein, Saskia A.M.J., van Duinen, Sjoerd G., van Roon-Mom, Willeke M.C. · 2014 · Reviews in the Neurosciences
APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease
Yue Jin Yang, Eiron Cudaback, Nikolas L. Jorstad, Jake F. Hemingway, Catherine E. Hagan, Erica J. Melief, Xianwu Li, Tom Yoo, Shawn B. Khademi, Kathleen S. Montine et al. · 2013 · American Journal Of Pathology
Bexarotene promotes microglia/macrophages - Specific brain - Derived Neurotrophic factor expression and axon sprouting after traumatic brain injury
Junchi He, Yike Huang, Han Liu, Xiaochuan Sun, Jingchuan Wu, Zhaosi Zhang, Liu Liu, Chao Zhou, Shaoqiu Jiang, Zhijian Huang et al. · 2020 · Experimental Neurology
Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases
Filippa Lo Cascio, Paola Marzullo, Rakez Kayed, Antonio Palumbo Piccionello · 2021 · Biomedicines
Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model
Xue Mi, Haiqiao Du, Xinmeng Guo, Yan Wu, Long Shen, Yukun Luo, Dekun Wang, Qiuyue Su, Rong Xiang, Shijing Yue et al. · 2022 · Acta Biomaterialia
RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment
Iliya M. Lefterov, Jonathan Schug, Anaïs Mounier, Kyong Nyon Nam, Nicholas Francis Fitz, Radosveta P. Koldamova · 2015 · Neurobiology of Disease
RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers
Kyong Nyon Nam, Anaïs Mounier, Nicholas Francis Fitz, Cody M. Wolfe, Jonathan Schug, Iliya M. Lefterov, Radosveta P. Koldamova · 2016 · Scientific Reports
Extracellular Proteolysis of Apolipoprotein E (apoE) by Secreted Serine Neuronal Protease
Tamboli, Irfan Y., Heo, Dongeun, Rebeck, G. William · 2014 · PLoS ONE
The national biomarker development alliance: confronting the poor productivity of biomarker research and development
George H. Poste, Carolyn C. Compton, Anna D. Barker · 2014 · Expert Review of Molecular Diagnostics
Genome-Wide Analysis of miRNA Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease
Hongxue Luo, Qi Wu, Xiaoyang Ye, Yi Xiong, Jinyong Zhu, Junyu Xu, Yarui Diao, Duo Zhang, Maosheng Wang, Qiu JinHua et al. · 2014 · PLoS ONE
Olfactory Functions Scale with Circuit Restoration in a Rapidly Reversible Alzheimer's Disease Model
Ning Cheng, Ling Bai, Eric R. Steuer, Leonardo Belluscio · 2013 · Journal of Neuroscience
Retinoid x receptor modulation protects against ER stress response and rescues glaucoma phenotypes in adult mice
Yogita Dheer, Nitin Chitranshi, Veer Bala Gupta, Samridhi Sharma, Kanishka Pushpitha, Mojdeh Abbasi, Mehdi Mirzaei, Yuyi You, Stuart L. Graham, Vivek Gupta · 2019 · Experimental Neurology
Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
Barbara Miziak, Barbara Błaszczyk, Stanisław Jerzy Czuczwar · 2021 · Pharmaceuticals
Free Cholesterol Accelerates Aβ Self-Assembly on Membranes at Physiological Concentration
Mohtadin Hashemi, Siddhartha Banerjee, Yuri L. Lyubchenko · 2022 · International Journal of Molecular Sciences
Improvement of Memory Deficits and Amyloid-β Clearance in Aged APP23 Mice Treated with a Combination of Anti-Amyloid-β Antibody and LXR Agonist
Nicholas Francis Fitz, Emilie L. Castranio, Alexis Y. Carter, Ravindra B. Kodali, Iliya M. Lefterov, Radosveta P. Koldamova · 2014 · Journal of Alzheimer s Disease
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1–42
Helena Janíčková, Vladimír Rudajev, Pavel Zimčík, Ján Jakubík, Heikki Tanila, Esam E. El‐Fakahany, Vladimı́r Doležal · 2012 · Neuropharmacology
Effect of a retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness in a murine model of asthma
Utako Fujii, Nobuaki Miyahara, Akihiko Taniguchi, Naohiro Oda, Daisuke Morichika, Etsuko Murakami, Hikari Nakayama, Koichi Waseda, Mikio Kataoka, Hiroki Kakuta et al. · 2017 · Respiratory Research
Oligomeric amyloid-β peptide disrupts olfactory information output by impairment of local inhibitory circuits in rat olfactory bulb
Hu, Bin, Geng, Chi, Hou, Xiao-Yu · 2017 · Neurobiology of Aging
Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model
José Morales‐Corraliza, Stephen D. Schmidt, Matthew J. Mazzella, Jason D. Berger, Donald A. Wilson, Daniel W. Wesson, Mathias Jucker, Efrat Levy, Ralph A. Nixon, Paul M. Mathews · 2012 · Neurobiology of Aging
Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy
Mikko T. Huuskonen, Sanna H. Loppi, Hiramani Dhungana, Velta Keksa-Goldsteine, Sighild Lemarchant, Paula Korhonen, Sara Wojciechowski, Eveliina Pollari, Piia K. Valonen, Juho Koponen et al. · 2016 · Scientific Reports
Towards Personalized Intervention for Alzheimer’s Disease
Xing Peng, Peiqi Xing, Xiuhui Li, Ying Qian, Fuhai Song, Zhouxian Bai, Guangchun Han, Hongxing Lei · 2016 · Genomics Proteomics & Bioinformatics
Nanotherapeutic strategies for the treatment of neurodegenerative diseases
Meng Huang, Xiao Qin Gu, Xiaoling Gao · 2018 · Elsevier eBooks
HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage
Yajun Xie, Xiaoyan Lv, Dongsheng Ni, Jianing Liu, Yanxia Hu, Yamin Liu, Yunhong Liu, Rui R Liu, Hui Zhao, Zhimin Lu et al. · 2019 · Nature Communications
Using a Caenorhabditis elegans Parkinson’s Disease Model to Assess Disease Progression and Therapy Efficiency
Samantha Hughes, Maritza van Dop, Nikki Kolsters, David van de Klashorst, Anastasia Pogosova, Anouk M. Rijs · 2022 · Pharmaceuticals
Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies
Cong Li, Xiaodan Guo, Min Lei, Jiayi Wu, Jia-zhen Jin, Xiaofan Shi, Zhiyuan Zhu, Vatcharin Rukachaisirikul, Lihong Hu, Tieqiao Wen et al. · 2016 · Acta Pharmacologica Sinica